We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

45 hedge funds and large institutions have $480M invested in Akcea Therapeutics Inc in 2017 Q3 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$162M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$59.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$19.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.7M
5
BlackRock
BlackRock
New York
+$15.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$243M +$162M +8,768,569 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$89.2M +$59.7M +3,223,888 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$29.7M +$19.9M +1,074,960 New
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$26.4M +$17.7M +955,568 New
BlackRock
5
BlackRock
New York
$23.2M +$15.5M +837,952 New
EAM
6
Eventide Asset Management
Massachusetts
$11.6M +$7.77M +420,000 New
GIM
7
Granahan Investment Management
Massachusetts
$8.53M +$5.71M +308,211 New
OAM
8
Oxford Asset Management
United Kingdom
$6.87M +$4.53M +244,764 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$5.57M +$3.73M +201,393 New
CS
10
Candriam SCA
Luxembourg
$5.31M +$3.56M +192,058 New
State Street
11
State Street
Massachusetts
$4.55M +$3.05M +164,628 New
Northern Trust
12
Northern Trust
Illinois
$4.51M +$3.02M +163,181 New
AGA
13
Altrinsic Global Advisors
Connecticut
$3.46M +$2.31M +125,000 New
USAA
14
United Services Automobile Association
Texas
$2.71M +$1.81M +97,780 New
ACM
15
Atika Capital Management
New York
$2.49M +$1.67M +90,000 New
TCIM
16
TIAA CREF Investment Management
New York
$1.83M +$1.22M +66,139 New
Charles Schwab
17
Charles Schwab
California
$1.65M +$1.11M +59,761 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$1.41M +$945K +51,068 New
Deutsche Bank
19
Deutsche Bank
Germany
$814K +$546K +29,490 New
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$810K +$542K +29,289 New
TA
21
Teachers Advisors
New York
$739K +$494K +26,702 New
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$672K +$450K +24,300 New
Morgan Stanley
23
Morgan Stanley
New York
$653K +$437K +23,617 New
MLICM
24
Metropolitan Life Insurance Company (MetLife)
New York
$457K +$306K +16,529 New
Bank of America
25
Bank of America
North Carolina
$440K +$295K +15,914 New
1
2

AKCA Hedge Fund Activity: Q3 2017 in Review

45 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2017, worth a combined $480M.

Buyers outnumbered sellers: 45 funds opened new AKCA positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $162M.

  • 45 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2017, up from 0 in Q2 2017.
  • Funds reported $480M of Akcea Therapeutics Inc stock for Q3 2017.
  • 45 funds opened new Akcea Therapeutics Inc positions in Q3 2017 and 0 closed out, a net change of +45 holders.
  • The largest Akcea Therapeutics Inc buyer in Q3 2017 was Fidelity Investments, an estimated $162M added.

Based on aggregated 13F filings for Q3 2017.